Corix Bioscience

Corix Bioscience Total Assets

The Total Assets of Corix Bioscience (CXBS) as of Oct 28, 2026 is 11.37 M USD. In the previous year, Total Assets was 9.42 M USD — a change of 20.73% (higher).

Total Assets

11.37 MUSD

YoY

20.73%

Last updated:

Total Assets of Corix Bioscience is 2016 11.37 M USD. Total Assets of Corix Bioscience was 2015 9.42 M USD. It decreases by 20.73% higher compared to the previous year.

The Corix Bioscience Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2014
461.00 USD
Jan 1, 2015
9.42 M USD
Jan 1, 2016
11.37 M USD
The Corix Bioscience Total Assets history
YEARTotal AssetsYoY
11.37 MUSD+20.73%
9.42 MUSD+2.04 M%
461.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corix Bioscience Stock analysis

What does Corix Bioscience do? Corix Bioscience is a company specialized in the production of cannabinoid-based products. It was founded in 2014 under the name American Housing Income Trust, a holding company focused on the American real estate market. In 2017, the company decided to restructure and change its name to Corix Bioscience. Since then, the company has become one of the leading manufacturers of CBD oils and other cannabinoid-based products. Corix Bioscience's business model is based on state-of-the-art technologies and innovation in the cannabinoid industry. The company collaborates with other firms to develop new products tailored to patient needs. The company aims to provide patients with a natural and safe alternative to conventional medical therapy. Corix Bioscience has five divisions. These include "Corix Bioscience," which focuses on the development of CBD-based products for the European market. "Corix Health" develops cannabinoid-based products specifically tailored to patient needs. "Subsidiaries" is responsible for collaborating with other companies to expand the product offering. "Licensing" offers licenses for technologies and rights to use innovative products. "Research and Development" focuses on advancing research and technologies in the cannabinoid industry. One of Corix Bioscience's most well-known products is CBD oil. It is extracted from specially bred hemp plants and is used for pain relief, anxiety, and other ailments. The company also offers CBD-based cosmetic products and food. Corix Bioscience is headquartered in Fresno, California, and is now internationally active. The company places special emphasis on the quality of its products and uses only natural and certified ingredients. Corix Bioscience advocates for fair and sustainable production and focuses on environmental protection and sustainability. The future prospects for Corix Bioscience are promising. The company operates in a forward-thinking market, focusing on innovation and sustainability. The developments in the market for cannabinoid-based products allow Corix Bioscience to expand its portfolio and offer more patients a natural alternative to conventional medical therapy. Corix Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corix Bioscience stock

Total Assets of Corix Bioscience is 11.37 M USD in 2016.

Total Assets of Corix Bioscience changed from 9.42 M USD to 11.37 M USD, representing a 20.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets Corix Bioscience since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's Corix Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Corix Bioscience

All Key Metrics — Corix Bioscience